Optimization of the sulforhodamine B colorimetric assay

Journal of Immunological Methods

Volumn 208, Issue 2, 1997, Pages 151-158

  Papazisis, K T ^a   Geromichalos, G D ^a   Dimitriadis, K A ^a   Kortsaris, A H ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Adherent cell lines; Cytotoxicity; Fixation; Sulforhodamine B

Indexed keywords

PACLITAXEL; REAGENT; RHODAMINE B; SULFORHODAMINE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CHEMOSENSITIVITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL ADHESION; COLORIMETRY; CULTURE MEDIA; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HT29 CELLS; HUMANS; MICE; MICROCHEMISTRY; PACLITAXEL; RHODAMINES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031455286     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00137-3     Document Type: Article

References (22)

1. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589.
2. Arnould R., Dubois J., Abikhalil F., Libert A., Ghanem G., Atassi G., Hanocq M., Lejeune F.J. Comparison of two cytotoxicity assays, tetrazolium derivative reduction (MTT) and tritiated thymidine uptake, on three malignant human cell lines using chemotherapeutic agents and investigational drugs. Anticancer Res. 10:1990;145.
3. Fogh, J., Trempelln, G., 1975. In: Fogh, J. (Ed.), Human Tumor Cells in vitro. Plenum Press, New York, p. 115.
4. Fricker S.P., Buckley R.G. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumor agents. Anticancer Res. 16:1996;3755.
5. Gey G.O., Coffman W.D., Kubicek M.T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:1952;264.
6. Higgins J.D. III, Neely L., Fricker S. Synthesis and cytotoxicity of some cyclometallated palladium complexes. J. Inorg. Biochem. 49:1993;149.
7. Jabbar S.A.B., Twentyman P.R., Watson J.V. The MTT assay underestimates the growth inhibitory effects of interferons. Br. J. Cancer. 60:1989;523.
8. Keepers Y.P., Pizao P.E., Peters G.J., van Ark-Otte J., Winograd B., Pinedo H.M. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur. J. Cancer. 27:1991;897.
9. Kerkvliet G.J. Drug discovery screen adapts to changes. J. Natl. Cancer Inst. 82:1990;1087.
10. Kubota T., Takahara T., Nagata M., Furukawa T., Kase S., Tanino H., Ishibiki K., Kitajima M. Colorimetric chemosensitivity testing using sulforhodamine B. J. Surg. Oncol. 52:1993;83.
11. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Cambell H., Mayo J., Boyd M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83:1991;757.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55.
13. Paull K.D., Shomaker R.H., Boyd M.R., Parsons J.L., Risbood P.A., Barbera W.A., Sharma M.N., Baker D.C., Hand E., Scudiero D.A., Monks A., Alley M.C., Grote M. The synthesis of XTT: A new tetrazolium reagent that is bioreducible to a water-soluble formazan. J. Heterocyclic Chem. 25:1988;911.
14. Perez R.P., Godwin A.K., Handel L.M., Hamilton T.C. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Eur. J. Cancer. 29A:1993;395.
15. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., Scudiero D.A., Monks A., Boyd M.R. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst. 82:1990;1113.
16. Sanford K.K., Earle W.R., Likely G.D. The growth in vitro of single isolated tissue cells. J. Natl. Cancer Inst. 9:1948;229.
17. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:1988;4827.
18. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer. Inst. 82:1990;1107.
19. Skehan, P., 1995. Assays of cell growth and cytotoxicity. In: Studzinski (Ed.), Cell Growth and Apoptosis. A Practical Approach. Oxford University Press, New York, p. 169.
20. Soule H.D., Vazquez L., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1973;1409.
21. Speicher L.A., Barone L.R., Champan A.E., Hudes G.R., Laing N., Smith C.D., Tew K.D. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine. J. Natl. Cancer Inst. 86:1994;688.
22. Wilson J.K., Sargent J.M., Elgie A.W., Hill J.G., Taylor C.G. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy. Br. J. Cancer. 62:1990;189.